We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For the first time, patients with certain types of advanced or recurrent endometrial cancer could access a treatment shown to slow its progression
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Innovative researchers working to tackle some of the hardest-to-treat cancers, including through the use of AI, have received a £2 million funding boost.
Casgevy (exagamglogene autotemcel) is based on the innovative gene-editing tool CRISPR, which won its inventors the Nobel Prize in 2020
How to support patients in accessing population screening programmes and obtaining screening results.
This advice has been written by the Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG) at the request of the Medicines and Healthcare products Regulatory Agency (MHRA – UK regulator). It is in the form of questions, asked of...
Volume 52 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Volume 39 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Millions invested in eight innovative companies behind lifesaving new medical technology which could destroy liver cancer tumours, detect Alzheimer’s and quickly spot those at risk of stroke
Government to take forward UK National Screening Committee recommendation on use of digital images to make it easier to identify cancer and speed up diagnosis.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (27 December) approved the advanced melanoma medicine Opdualag (nivolumab-relatlimab) for patients from the age of 12.
SaBTO recommendations on the donation of starting material for cell-based advanced therapies.
Volume 17 of the non-technical summaries granted under the Animals (Scientific Procedures) Act 1986 during 2013.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).